Home β€Ί Healthcare β€Ί Diagnostics β€Ί Global Consumer DNA (Genetic) Testing Market

Global Consumer DNA (Genetic) Testing Market Size, Share, Opportunities, COVID 19 Impact, And Trends By Gender (Male, Female), By Age Group (0-15 Years, 15-30 Years, 30-60 Years, Above 60 Years), Application (Identity Seeking, Disease Risk, Curiosity Driven), And By Geography - Forecasts From 2025 To 2030

πŸ“₯ Download Free SampleπŸ’¬ Speak to Analyst
$3,950
Single User License
Access Full Insights
Report OverviewSegmentationTable of ContentsCustomize Report

Report Overview

Consumer DNA (Genetic) Testing Market Size:

The Global Consumer DNA (Genetic) Testing Market will soar from USD 1,813.099 million in 2025 to USD 3,161.211 million in 2030, with an 11.76% compound annual growth rate (CAGR).

Genetic or DNA testing usually refers to medical tests that examine and evaluates the changes in chromosomes, genes, or several types of proteins to help a person’s chance of developing one or rule out a suspected genetic condition. The market is expected to surge in the coming years, due to the rise in the demand for direct-to-consumer genetic testing, identity seeking, and other related factors. Increasing and raising awareness about novel developments and advancements in the DNA testing market is expected to play a major role in the overall market growth. Major companies such as Ancestry and 23andMe have been investing a significant sum of capital to develop advanced and innovative superior and excellent direct-to-consumer genetic testing and other related solutions. Moreover, the growth in genetic ancestry testing is also expected to play a major and imperative role in the market growth, during the forecast period. These trends are expected to have a positive impact on the market, in the coming years.

Consumer DNA (Genetic) Testing Market Driver:

  • A rise in Genetic Ancestry Testing

Genetic ancestry testing is defined as a way for an individual to learn more about his family’s genealogy or want to go beyond data collection from historical documentation. There has been a surge in the demand for ancestry testing, with the use of cheek swabs or saliva DNA test kits, especially in the regions like Europe and North America. According to the data given by the MIT Institute and Technology, more than 26 million customers had added their respective DNA to four major health databases and commercial ancestry. Moreover, according to Ancestry and 23andMe, two of the major players in the market, the companies have now a collection of some of the world’s biggest collections of human DNAs. With the affordable pricing of around US$59, these DNA tests offer a plethora of entertainment, a major chance of discovering family and ancestry secrets, such as estranged siblings. Ancestry also claimed that they had registered a record Thanksgiving sale in the month of November 2018 and sold a total number of test kits at around 14 million. Moreover, other companies are also making significant developments in the market. For instance, Gene By Gene, one of the major firms in the market, had stated that its family tree DNA ancestry database contains approx. 2 million people. Another company, known as MyHeritage, a major Israeli firm, had stated that their database has around 2.5 million profiles. Moreover, the growth in direct-to-consumer DNA testing is also expected to have a major impact on the market. According to several official figures, there had been an expectation of sales of around 100 million kits by the year 2021. A plethora of companies has been providing DNA testing services to their customers, in the past few years. For instance, in December 2020, MyHeritage, a major global service for identifying your past and future company, announced the launch of genetic groups.

The genetic groups would be able to identify and find ancestral origins with high-resolution data of around 2100 geographic regions. This development is expected to enhance the company’s market share, in the coming years. Other players are also making significant developments in the market. In January 2021, myDNA, a major Australian genomics company, announced a merger with FamilyTreeDNA, a US-based consumer DNA test company, and with Gene By Gene, the parent company of FamilyTreeDNA. The innovative merger of these companies is expected to be a major development for the market, as the companies would aim to focus on the enhancement of a scientific foundation for personalized and actionable insights. Asia Pacific region is expected to have a major share in the market, due to the rise in the number of start-ups and increasing excitement about ancestral DNA testing.

Market Segmentation:

  • By Type
    • Carrier Testing
    • Ancestry Testing
    • Predictive Testing
    • Others
  • By Sample Type
    • Saliva
    • Cheek Swab
    • Others
  • By Distribution Channel
    • Online
    • Offline
  • By Application
    • Kinship
    • Ancestry & Genealogy
    • Health & Wellness Testing
    • Others
  • By Geography
    • North America
      • USA
      • Canada
      • Mexico
    • South America
      • Brazil
      • Argentina
      • Others
    • Europe
      • Germany
      • France
      • United Kingdom
      • Italy
      • Spain
      • Others
    • Middle East and Africa
      • Saudi Arabia
      • UAE
      • Israel
      • Others
    • Asia Pacific
      • China
      • India
      • Japan
      • South Korea
      • Indonesia
      • Thailand
      • Taiwan
      • Others

REPORT DETAILS

Report ID:KSI061611330
Published:Nov 2025
Pages:150
Format:PDF, Excel, PPT, Dashboard
πŸ“₯ Download SampleπŸ“ž Speak to AnalystπŸ“§ Request Customization

Need Assistance?

Our research team is available to answer your questions.

Contact Us

Frequently Asked Questions

The global consumer DNA testing market is expected to reach a market size of US$2,703.608 million by 2026.

The consumer DNA (Genetic) testing market is expected to grow at a CAGR of 12.25% over the forecast period.

Consumer DNA (Genetic) Testing Market was valued at US$1,204.395 million in 2019.

Major industry players profiled as part of the consumer DNA testing market report are Quest Diagnostics Inc., Positive Bioscience, Mapmygenome India, MyMedLab, Laboratory Corporation of America, Gene by Gene, among others.

The consumer DNA testing market is expected to surge in the coming years, due to the rise in the demand for direct-to-consumer genetic testing, identity seeking, and other related factors.

Related Reports

Healthcare

Smart Structural Health Monitoring Market - Forecasts from 2026 to 2031

Jan 2026
Healthcare

Taiwan RUO Immunoassay Market Size, Share, Opportunities, And Trends By Product Type (Immunoassay Kits, Immunoassay Reagents, Microplate Reader, Microplates, Analyzers (Automated Analyzers, Non-Automated Analyzers), Microplate Washers, Others), By Sample Type (Plasma, Blood Serum, Urine, Saliva, Cell or Tissue Culture Medium, Others), By Application (Oncology, Blood Screening and Toxicology, Infectious Disease, Cardiology, Allergy Diagnostic, Rare and Emerging Condition Diagnostic, Others), And By End-User (Research and Academic Laboratories, Pharmaceutical and Biotechnology Companies) - Forecasts From 2025 To 2030

Jun 2025
Healthcare

Indonesia RUO Immunoassay Market Size, Share, Opportunities, And Trends By Product Type (Immunoassay Kits, Immunoassay Reagents, Microplate Reader, Microplates, Analyzers (Automated Analyzers, Non-Automated Analyzers), Microplate Washers, Others), By Sample Type (Plasma, Blood Serum, Urine, Saliva, Cell or Tissue Culture Medium, Others), By Application (Oncology, Blood Screening and Toxicology, Infectious Disease, Cardiology, Allergy Diagnostic, Rare and Emerging Condition Diagnostic, Others), By End-User (Research and Academic Laboratories, Pharmaceutical and Biotechnology Companies), And By City - Forecasts From 2025 To 2030

Jun 2025
Healthcare

South Korea RUO Immunoassay Market Size, Share, Opportunities, And Trends By Product Type (Immunoassay Kits, Immunoassay Reagents, Microplate Reader, Microplates, Analyzers (Automated Analyzers, Non-Automated Analyzers), Microplate Washers, Others), By Sample Type (Plasma, Blood Serum, Urine, Saliva, Cell or Tissue Culture Medium, Others), By Application (Oncology, Blood Screening and Toxicology, Infectious Disease, Cardiology, Allergy Diagnostic, Rare and Emerging Condition Diagnostic, Others), By End-User (Research and Academic Laboratories, Pharmaceutical and Biotechnology Companies), And By State - Forecasts From 2025 To 2030

Jun 2025
View All Reports